Advertisement
Advertisement


Medical News

Research Roundup: "Differences in Human Immunodeficiency Virus Care and Treatment Among Subpopulations in the United States"

June 24, 2013

Early diagnosis, antiretroviral therapy, prompt linkage to care and continued access to care reduce the human immunodeficiency virus (HIV) transmission and related illness and death. Noting that disparities in care and treatment for HIV exist and vary among population groups, authors analyzed data about all the people infected with HIV in the U.S., from the CDC's National HIV Surveillance System: "More than 850,000 persons with HIV did not have a suppressed viral load, including 79% of blacks, 74% of Hispanics or Latinos, and 70% of whites," the authors write. Younger adults, those under the age of 45 years, were less likely than others to be aware of their infection or have a suppressed viral load. "Increasing the percentage of young persons diagnosed and receiving continuous care is critical to addressing HIV in the United States, ... Ensuring that people stay in care and receive treatment will increase the proportion of HIV-infected individuals who achieve and maintain a suppressed viral load," they conclude. (Hall et al., JAMA Internal Medicine, 6/17)

Back to other news for June 2013


This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.




Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement